Application Sponsors
ANDA 203177 | XELLIA PHARMS APS | |
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | 50,000 UNITS/VIAL | 0 | BACITRACIN | BACITRACIN |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2014-08-25 | |
Submissions Property Types
TE Codes
CDER Filings
XELLIA PHARMS APS
cder:Array
(
[0] => Array
(
[ApplNo] => 203177
[companyName] => XELLIA PHARMS APS
[docInserts] => ["",""]
[products] => [{"drugName":"BACITRACIN","activeIngredients":"BACITRACIN","strength":"50,000 UNITS\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"Yes"}]
[labels] =>
[originalApprovals] => [{"actionDate":"08\/25\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2014-08-25
)
)